These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

883 related items for PubMed ID: 22396480

  • 1. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C.
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [Abstract] [Full Text] [Related]

  • 2. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK, Das T, Manos J, Kutter E, Morales S, Chan HK.
    AAPS J; 2019 Apr 04; 21(3):49. PubMed ID: 30949776
    [Abstract] [Full Text] [Related]

  • 3. Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients.
    Fong SA, Drilling A, Morales S, Cornet ME, Woodworth BA, Fokkens WJ, Psaltis AJ, Vreugde S, Wormald PJ.
    Front Cell Infect Microbiol; 2017 Apr 04; 7():418. PubMed ID: 29018773
    [Abstract] [Full Text] [Related]

  • 4. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
    Brüssow H.
    mBio; 2012 Apr 04; 3(2):. PubMed ID: 22493030
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
    Saussereau E, Vachier I, Chiron R, Godbert B, Sermet I, Dufour N, Pirnay JP, De Vos D, Carrié F, Molinari N, Debarbieux L.
    Clin Microbiol Infect; 2014 Dec 04; 20(12):O983-90. PubMed ID: 24920209
    [Abstract] [Full Text] [Related]

  • 6. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
    Sahota JS, Smith CM, Radhakrishnan P, Winstanley C, Goderdzishvili M, Chanishvili N, Kadioglu A, O'Callaghan C, Clokie MR.
    J Aerosol Med Pulm Drug Deliv; 2015 Oct 04; 28(5):353-60. PubMed ID: 25714328
    [Abstract] [Full Text] [Related]

  • 7. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, Rossitto M, Cariani L, Briani F, Debarbieux L, Ghisotti D.
    Antimicrob Agents Chemother; 2018 Jun 04; 62(6):. PubMed ID: 29555626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models.
    Kwiatek M, Parasion S, Rutyna P, Mizak L, Gryko R, Niemcewicz M, Olender A, Łobocka M.
    Res Microbiol; 2017 Apr 04; 168(3):194-207. PubMed ID: 27818282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
    Krylov VN.
    Adv Virus Res; 2014 Apr 04; 88():227-78. PubMed ID: 24373314
    [Abstract] [Full Text] [Related]

  • 12. [New Virulent Bacteriophages Active against Multiresistant Pseudomonas aeruginosa Strains].
    Balarjishvili NSh, Kvachadze LI, Kutateladze MI, Meskhi TSh, Pataridze TK, Berishvili TA, Tevdoradze ESh.
    Prikl Biokhim Mikrobiol; 2015 Apr 04; 51(6):600-9. PubMed ID: 26859962
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J, Furusawa T, Munby M, Kawaguchi C, Matsuda Y, Shiokura Y, Nakamura K, Nakamura T, Sasaki M, Usui M, Iwasaki T, Gondaira S, Higuchi H, Sawa H, Tamura Y, Iwano H.
    Microbiol Immunol; 2020 Nov 04; 64(11):778-782. PubMed ID: 32918505
    [Abstract] [Full Text] [Related]

  • 14. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T, Iwano H, Hiyashimizu Y, Matsubara K, Higuchi H, Nagahata H, Niwa H, Katayama Y, Kinoshita Y, Hagiwara K, Iwasaki T, Tanji Y, Yokota H, Tamura Y.
    Appl Environ Microbiol; 2016 Sep 01; 82(17):5332-9. PubMed ID: 27342558
    [Abstract] [Full Text] [Related]

  • 15. Characterization of five newly isolated bacteriophages active against Pseudomonas aeruginosa clinical strains.
    Kwiatek M, Mizak L, Parasion S, Gryko R, Olender A, Niemcewicz M.
    Folia Microbiol (Praha); 2015 Jan 01; 60(1):7-14. PubMed ID: 24993480
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a novel Pseudomonas aeruginosa bacteriophage, KPP25, of the family Podoviridae.
    Miyata R, Yamaguchi K, Uchiyama J, Shigehisa R, Takemura-Uchiyama I, Kato S, Ujihara T, Sakaguchi Y, Daibata M, Matsuzaki S.
    Virus Res; 2014 Aug 30; 189():43-6. PubMed ID: 24801109
    [Abstract] [Full Text] [Related]

  • 17. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
    Saussereau E, Debarbieux L.
    Adv Virus Res; 2012 Aug 30; 83():123-41. PubMed ID: 22748810
    [Abstract] [Full Text] [Related]

  • 18. Classification of 17 newly isolated virulent bacteriophages of Pseudomonas aeruginosa.
    Li L, Yang H, Lin S, Jia S.
    Can J Microbiol; 2010 Nov 30; 56(11):925-33. PubMed ID: 21076483
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
    Vinodkumar CS, Kalsurmath S, Neelagund YF.
    Indian J Pathol Microbiol; 2008 Nov 30; 51(3):360-6. PubMed ID: 18723958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.